Federal scheduling
LSD is Schedule I in most jurisdictions. Ketamine is Schedule III in the US. Most agencies will not engage.
Marketing for ketamine and psychedelic compound retailers in jurisdictions where legal.
Built for retailers operating in legal jurisdictions only, with a discreet acquisition posture and a customer base that values privacy as a feature.
Get in touch →Direct buys on harm-reduction-adjacent and privacy-focused publications.
Brand presence that respects the customer’s privacy expectation as a feature
Crypto-first checkout (XMR, BTC, USDT) with privacy-respecting flows.
Payment infrastructure aligned with customer privacy expectations
Engagement scope defined within the legal envelope, both jurisdictions.
Operational continuity inside the legal boundary
LSD is Schedule I in most jurisdictions. Ketamine is Schedule III in the US. Most agencies will not engage.
No mainstream paid acquisition is available. Acquisition has to be referral and search-driven.
Customers expect agency-level privacy. Most agency infrastructure does not meet the standard.
The buyer-intent search demand for ketamine & lsd is real, direct, and largely under-served by operators who do not invest in marketing infrastructure. The data below illustrates the categories your customers are already searching for. Ranking, paid placement, and direct-channel presence on these queries are direct revenue.
| Buyer-intent keyword | Monthly search volume |
|---|---|
| ketamine therapy | 40,500/mo |
| lsd therapy | 4,400/mo |
| ketamine treatment cost | 14,800/mo |
Local, eCom, parasite, PBN, negative-defense.
SVC-002Paid acquisition across compliant platforms and gray-market networks.
SVC-003Press, suppression, review management, crisis communication.
SVC-004Forum, Reddit, Discord, Telegram. Community-driven reach where it matters.
SVC-005Funnel, retention, upsell, conversion rate optimization.
SVC-006Conversion-tuned brand and store sites. Built for the vertical.
SVC-007Niche-fluent copy and editorial that respects the audience.
SVC-008Strategy, audits, contingency planning, founder advisory.
Privacy was the differentiator they sold us on, and they delivered it end to end.
Their insistence on jurisdictional clarity was annoying at first. Two years in, with zero exposure events, I am grateful.
Only in jurisdictions where the work is legal for the retailer and for us. Most engagement requests in this category we decline at the audit stage.
We treat clinics as a separate category — see Psychedelic Therapy. Different regulatory profile, different audience, different marketing playbook.
Only what we need to do the marketing. We do not audit your operations.
Privacy-respecting analytics with no PII leakage, server-side tagging where possible, and discreet attribution patterns. Customer privacy is a feature for this category, not a compliance afterthought.
Direct buys on harm-reduction-adjacent and privacy-focused publications. SEO into research-oriented and community sites. Direct relationships with biohacker creators where the legal envelope allows.
Most engagements start with a three-week audit. The form below tells us enough to scope the call. Or write directly: contacts@despitemarketing.com. Your brief goes straight to a partner, not a triage queue.